11/26/2013

CIVCO Medical Solutions has been cleared by the FDA to market its EX3 Stepper system for use in the diagnosis and treatment of prostate cancer. The company said the ultrasound-guided device, designed for both high-dose-rate and low-dose-rate brachytherapy, also received CE mark approval.

Related Summaries